We are live on
!
Find out more
Keros Therapeutics
KROS
KROS
88 hedge funds and large institutions have $545M invested in Keros Therapeutics in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
10% more funds holding
Funds holding: 80 → 88 (+8)
7% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 27
1.48% less ownership
Funds ownership: 60.6% → 59.12% (-1.5%)
9% less capital invested
Capital invested by funds: $599M → $545M (-$54M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
88
Holders Change
+8
Holders Change %
+10%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
25
Reduced
27
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$37.7M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$18.2M |
| 3 |
VA
VR Adviser
New York
|
-$11.6M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.04M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$4.42M |
